AT336021B - Verfahren zur herstellung des neuen 1-(3-(4-m-chlorphenyl-1-piperazinyl)-propyl)-3,4-diathyl-delta2-1,2,4-triazolin-5-ons und dessen salzen - Google Patents

Verfahren zur herstellung des neuen 1-(3-(4-m-chlorphenyl-1-piperazinyl)-propyl)-3,4-diathyl-delta2-1,2,4-triazolin-5-ons und dessen salzen

Info

Publication number
AT336021B
AT336021B AT871173A AT871173A AT336021B AT 336021 B AT336021 B AT 336021B AT 871173 A AT871173 A AT 871173A AT 871173 A AT871173 A AT 871173A AT 336021 B AT336021 B AT 336021B
Authority
AT
Austria
Prior art keywords
diathyl
delta2
triazoline
piperazinyl
chlorophenyl
Prior art date
Application number
AT871173A
Other languages
German (de)
English (en)
Other versions
ATA871173A (de
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ATA871173A publication Critical patent/ATA871173A/de
Application granted granted Critical
Publication of AT336021B publication Critical patent/AT336021B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT871173A 1972-10-16 1973-10-12 Verfahren zur herstellung des neuen 1-(3-(4-m-chlorphenyl-1-piperazinyl)-propyl)-3,4-diathyl-delta2-1,2,4-triazolin-5-ons und dessen salzen AT336021B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT53380/72A IT1052119B (it) 1972-10-16 1972-10-16 Derivati del triazolinone e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
ATA871173A ATA871173A (de) 1976-08-15
AT336021B true AT336021B (de) 1977-04-12

Family

ID=11282276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT871173A AT336021B (de) 1972-10-16 1973-10-12 Verfahren zur herstellung des neuen 1-(3-(4-m-chlorphenyl-1-piperazinyl)-propyl)-3,4-diathyl-delta2-1,2,4-triazolin-5-ons und dessen salzen

Country Status (19)

Country Link
US (1) US3857845A (US07642317-20100105-C00010.png)
JP (1) JPS5550948B2 (US07642317-20100105-C00010.png)
AR (1) AR204086A1 (US07642317-20100105-C00010.png)
AT (1) AT336021B (US07642317-20100105-C00010.png)
BE (1) BE806146A (US07642317-20100105-C00010.png)
CA (1) CA1013746A (US07642317-20100105-C00010.png)
CH (1) CH589643A5 (US07642317-20100105-C00010.png)
DE (1) DE2351739C3 (US07642317-20100105-C00010.png)
DK (1) DK141750B (US07642317-20100105-C00010.png)
ES (1) ES419687A1 (US07642317-20100105-C00010.png)
FI (1) FI58495C (US07642317-20100105-C00010.png)
FR (1) FR2202702B1 (US07642317-20100105-C00010.png)
GB (1) GB1438337A (US07642317-20100105-C00010.png)
IT (1) IT1052119B (US07642317-20100105-C00010.png)
KE (1) KE2823A (US07642317-20100105-C00010.png)
NL (1) NL184782C (US07642317-20100105-C00010.png)
NO (1) NO138565C (US07642317-20100105-C00010.png)
SE (1) SE390819B (US07642317-20100105-C00010.png)
YU (1) YU39914B (US07642317-20100105-C00010.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1047702B (it) * 1975-07-24 1980-10-20 Acraf Nuova sintesi degli psicofarmaci denominati trazodone ed eteroperidone
US4162318A (en) * 1976-05-05 1979-07-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of trazodone and etoperidone in Parkinsonism and in other extrapyramidal syndromes characterized by tremors
IT1073639B (it) * 1976-05-05 1985-04-17 Acraf Impiego del trazodone e etoperidone nel morbo di parikinson ed in altre sindromi extrapiramidali caratterizzate da tremori
US4465683A (en) * 1979-09-14 1984-08-14 Mead Johnson & Company Anti-psychotic agents
US4254124A (en) * 1979-09-24 1981-03-03 Mead Johnson & Company Antidepressant agent
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US4931445A (en) * 1988-10-06 1990-06-05 Irwin Goldstein Agents for treatment of male impotence
US5229406A (en) * 1990-09-19 1993-07-20 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5140036A (en) * 1990-09-19 1992-08-18 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5087634A (en) * 1990-10-31 1992-02-11 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5238952A (en) * 1990-10-31 1993-08-24 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors

Also Published As

Publication number Publication date
DK141750C (US07642317-20100105-C00010.png) 1980-11-03
ATA871173A (de) 1976-08-15
DE2351739C3 (de) 1980-09-04
NL184782C (nl) 1989-11-01
FI58495B (fi) 1980-10-31
NL7314204A (US07642317-20100105-C00010.png) 1974-04-18
AR204086A1 (es) 1975-11-20
DE2351739B2 (de) 1980-01-10
SE390819B (sv) 1977-01-24
IT1052119B (it) 1981-06-20
BE806146A (fr) 1974-02-15
NO138565C (no) 1978-09-27
YU263473A (en) 1983-02-28
JPS4993381A (US07642317-20100105-C00010.png) 1974-09-05
US3857845A (en) 1974-12-31
NL184782B (nl) 1989-06-01
DK141750B (da) 1980-06-09
YU39914B (en) 1985-06-30
CA1013746A (en) 1977-07-12
JPS5550948B2 (US07642317-20100105-C00010.png) 1980-12-20
FR2202702A1 (US07642317-20100105-C00010.png) 1974-05-10
NO138565B (no) 1978-06-19
FI58495C (fi) 1981-02-10
ES419687A1 (es) 1976-10-16
GB1438337A (US07642317-20100105-C00010.png) 1976-06-03
KE2823A (en) 1978-03-31
FR2202702B1 (US07642317-20100105-C00010.png) 1976-07-02
DE2351739A1 (de) 1974-04-18
CH589643A5 (US07642317-20100105-C00010.png) 1977-07-15

Similar Documents

Publication Publication Date Title
AT336021B (de) Verfahren zur herstellung des neuen 1-(3-(4-m-chlorphenyl-1-piperazinyl)-propyl)-3,4-diathyl-delta2-1,2,4-triazolin-5-ons und dessen salzen
AT331258B (de) Verfahren zur herstellung von neuen 1,2,3-oxathiazin-4-onen
ATA636673A (de) Verfahren zur herstellung von neuen 1-(3- (5,6,7,8-tetrahydronaphth-1-yl-oxy) -propyl)-piperazin-derivaten und deren salzen
AT315147B (de) Verfahren zur Herstellung von neuen N<1>-Alkoxyalkyliden-3,5-dinitro-sulfanilamiden
AT340431B (de) Verfahren zur herstellung des neuen 1-(3-(4-m-chlorphenyl-1-piperazinyl)-propyl)-3,4-diathyl-delta2-1,2,4-triazolin-5-on und dessen pharmakologisch verwendbaren salzen
AT323756B (de) Verfahren zur herstellung des neuen n-(1,1-diphosphonoäthyl)-acetamidins
AT327904B (de) Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT327902B (de) Verfahren zur herstellung von neuen 3,4-dihydropyridonen
AT320846B (de) Verfahren zur Herstellung des neuen 3',4'-Dideoxykanamycins B
ATA910173A (de) Verfahren zur herstellung von neuen 11,12-secoprostaglandinen
AT326842B (de) Verfahren zur herstellung von neuen 9,10-secoöstran-derivaten
AT331797B (de) Verfahren zur herstellung des neuen 1,3-bis- (beta-athylhexyl)-5-amino-5-methyl-hexahydropyrimidin-pyridin-3-carboxylats
AT332001B (de) Verfahren zur herstellung der neuen 20beta-hydroxy-9-oxo- 1,2,3,4,10,19 -hexanor-5,9-seco-pregnan-5-saure
PT65438A (de) Verfahren zur herstellung des neuen l-benzoyl-2-(2',6'-dichlorphenylamino)-2-imidazolin und von dessen salzen
AT326837B (de) Verfahren zur herstellung von neuen 2,2'-anhydro-1-beta-d-arabinofuranosyl-5-fluorcytosin-hydrofluorid, -hydrochlorid oder -hydrobromid
AT325595B (de) Verfahren zur herstellung des neuen 1,3,3-trimethyl-1-octylaminomethyl-5-octylamino-cyclohexans
ATA814773A (de) Verfahren zur herstellung des neuen 1,3,3-trimethyl-1-dodecylaminomethyl-5-aminocyclohexans
AT329074B (de) Verfahren zur herstellung des neuen 8,10-diaza-6-hydroxy -5- methyl-1- (2'-methyl-1',2',3'-trihydroxy-propyl) -2-oxa-bicyclo (4,2,2) decan-7,9-dions
AT338765B (de) Verfahren zur herstellung des neuen 2,2,2-trichlor-4'-tert.butylacetophenon
ATA587574A (de) Verfahren zur herstellung des neuen n-propyl-tert.amylamins
ATA474373A (de) Verfahren zur herstellung des neuen n-beta-diathylaminoathyl)-2-methoxy-5-methylsulfonylbenzamids, seiner pharmazeutisch akzeptablen saureadditionssalze und quaternaren salze
ATA894774A (de) Verfahren zur herstellung von neuen 1-(4-amino-3',5'-dihalogenphenyl)-2-cycloalkylaminoathanolen
AT342791B (de) Verfahren zur herstellung der neuen 5,11-methylen-tetrahydrohomofolsaure
ATA690174A (de) Verfahren zur herstellung des neuen 4-(n-propyl)-n-heptanol-3-carbamates
AT323714B (de) Verfahren zur herstellung von neuen 6,9-dioxo-8-hydroxy-2-suestituierten-bicyclo-(3,3,1)-non-7-en-3-olen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee